Research organization, collaborating with the global scientific community to increase survival and enrich quality of life for patients needing cellular therapy. Learn more at cibmtr.org.https://bsky.app/profile/cibmtr.bsky.socialhttps://bsky.app/profile/cibmtr.bsky.social/post/3mlvvy7cjvi2eWant the newest transplant research at your fingertips? You can now sort our Study Summaries by date—making it simple to track recent findings and stay informed as new studies roll out. Take a look ➡️ cibmtr.org/summaries15 May 2026 18:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mlvvy7cjvi2ehttps://bsky.app/profile/cibmtr.bsky.social/post/3mltsweqdno2x🚨 New for 2026! 🚨 After #Tandem26, CIBMTR is proud to share the accepted Working Committee studies—advancing innovation in cellular therapy & transplantation. See the full list: 🔗 https://cibmtr.org/Files/2026-New-studies-on-website.pdf #CIBMTR #CellTherapy #BMT #Research14 May 2026 22:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mltsweqdno2xhttps://bsky.app/profile/cibmtr.bsky.social/post/3mjpiweeave2mTrustworthy transplant research—now easier to find. Explore Study Summaries organized by disease and condition: lymphoma, multiple myeloma, sickle cell disease, and more. Start exploring ➡️cibmtr.org/summaries 17 Apr 2026 18:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mjpiweeave2mhttps://bsky.app/profile/cibmtr.bsky.social/post/3mi2p5bkiml2gOur study summaries page just got a major upgrade! Search by category, find what you need faster, and browse clear, plain‑language summaries. Explore the new layout ➡️ cibmtr.org/summaries27 Mar 2026 18:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mi2p5bkiml2ghttps://bsky.app/profile/cibmtr.bsky.social/post/3mhumocklzz2dToday at #EBMT26: Hear about outcomes from the NMDP-sponsored ACCESS trial:25 Mar 2026 08:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhumocklzz2dhttps://bsky.app/profile/cibmtr.bsky.social/post/3mhs47fn2sm2xLive at #EBMT26 today: CIBMTR oral and poster abstracts! Take a look:24 Mar 2026 08:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhs47fn2sm2xhttps://bsky.app/profile/cibmtr.bsky.social/post/3mhqezwg4a22x📢 Now Hiring: Program Director I – Statistical Operations (CIBMTR) Lead biostatistics teams and collaborate with medical & scientific researchers across the full research lifecycle, advancing high‑impact BMT research. 🔗 Apply: https://mcw.wd503.myworkdayjobs.com/ExternalCareers/job/Remote-Wisconsin/Program-Director-I---CIBMTR_JR101330 #Hiring #Biostatistics23 Mar 2026 15:32 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhqezwg4a22xhttps://bsky.app/profile/cibmtr.bsky.social/post/3mhplqha2b72vAttending #EBMT26? Make sure to check out these abstracts today. Don’t miss these oral and poster abstracts!23 Mar 2026 08:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhplqha2b72vhttps://bsky.app/profile/cibmtr.bsky.social/post/3mhmxwalaj62e#EBMT26 begins today! Here’s the full schedule of CIBMTR abstracts being presented this week.22 Mar 2026 07:00 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhmxwalaj62ehttps://bsky.app/profile/cibmtr.bsky.social/post/3mhjbrm6d6425Coming soon to #EBMT26: CIBMTR will present a variety of oral and poster abstracts. Here’s a quick overview of when this research will be featured throughout the meeting.20 Mar 2026 19:45 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhjbrm6d6425https://bsky.app/profile/cibmtr.bsky.social/post/3mhegyyiamb26New tool predicts acute graft-vs-host disease after transplant. Read about this CIBMTR study to learn more:https://cibmtr.org/Patient-Summaries/New-tool-predicts-acute-graft-vs-host-disease-after-transplant.htm18 Mar 2026 21:36 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mhegyyiamb26https://bsky.app/profile/cibmtr.bsky.social/post/3mg6babg53n2tCHARM predicts who may need extra care after transplant. Read about this CIBMTR study to learn more: https://cibmtr.org/Patient-Summaries/CHARM-predicts-who-may-need-extra-care-after-transplant.htm03 Mar 2026 17:11 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mg6babg53n2thttps://bsky.app/profile/cibmtr.bsky.social/post/3mg3mv4ejbn2rPeople with sickle cell trait can safely donate bone marrow. Read about this CIBMTR study to learn more: https://cibmtr.org/Patient-Summaries/People-with-sickle-cell-trait-can-safely-donate-bone-marrow.htm02 Mar 2026 16:02 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mg3mv4ejbn2rhttps://bsky.app/profile/cibmtr.bsky.social/post/3mfrzhmtgza2bGraphs can help patients and doctors see healing over time. Read about this CIBMTR study to learn more: https://cibmtr.org/Patient-Summaries/Graphs-can-help-patients-and-doctors-see-healing-over-time.htm 26 Feb 2026 20:20 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mfrzhmtgza2bhttps://bsky.app/profile/cibmtr.bsky.social/post/3mfa6j2bnpm25Some children with SCID might not need chemotherapy before transplant or GVHD medicines after transplant. Read about this CIBMTR study to learn more: https://cibmtr.org/Patient-Summaries/Some-children-with-SCID-might-not-need-chemotherapy-before-transplant-or-GVHD-medicines-after-transplant.htm19 Feb 2026 18:03 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mfa6j2bnpm25https://bsky.app/profile/cibmtr.bsky.social/post/3meoqtp35h22jDon't miss this! Abstracts from #Tandem26 are now available to view online. Explore the full collection here: https://www.astctjournal.org/issue/S2666-6367(25)X0017-812 Feb 2026 19:43 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3meoqtp35h22jhttps://bsky.app/profile/cibmtr.bsky.social/post/3mea5ejrqtc2bA special congratulations to Dr. Stella Davies, our #Tandem26 Mortimer M. Bortin lecturer! It is our pleasure to now hear, “Waiting until Evening to See How Splendid the Day Has Been: Aging and Transplant at the Extremes of the Lifespan” this evening!07 Feb 2026 00:17 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mea5ejrqtc2bhttps://bsky.app/profile/cibmtr.bsky.social/post/3mea4txl56s2oCongratulations to CIBMTR Distinguished Service Award recipient, Dr. Parvez Ahmed at #Tandem2607 Feb 2026 00:08 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3mea4txl56s2ohttps://bsky.app/profile/cibmtr.bsky.social/post/3me7xazuuv22yDr. Rachel Cusatis, CIBMTR Senior Scientific Director, is now presenting oral abstract, “Mismatch Doesn’t Mean Misfortune: Quality of Life after HCT in the ACCESS Trial,” at #Tandem26.06 Feb 2026 22:28 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3me7xazuuv22yhttps://bsky.app/profile/cibmtr.bsky.social/post/3me7jaixqys25Have you had a chance to visit the #Tandem26 exhibit hall? Make sure to stop by the Tandem Meetings Hub to visit with CIBMTR staff! Open today until 3 p.m. and 9 a.m.-12 p.m. tomorrow!06 Feb 2026 18:17 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3me7jaixqys25https://bsky.app/profile/cibmtr.bsky.social/post/3me7gm3vjik2nA Wednesday session at #Tandem26 took a closer look at where gene therapy stands today—what’s working, what’s holding it back, and what’s coming next. Check out the full recap in Tandem Meeting News: https://www.tandemmeetingsnews.com/experts-discuss-potential-developments-and-challenges-in-gene-therapies/?utm_source=facebook&utm_medium=social&utm_campaign=CIBMTR-2026-day-3-assoc-facebook-share-custom-graphic&utm_content=link-share06 Feb 2026 17:30 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3me7gm3vjik2nhttps://bsky.app/profile/cibmtr.bsky.social/post/3me7cpm7imk2nWhat's next for HCT and cellular therapies? The #Tandem26 opening-day plenary examined progress from breakthrough to bedside — looking toward equitable access and improved care. Read more in Tandem Meeting News: https://www.tandemmeetingsnews.com/joint-plenary-session-marks-successes-and-challenges-of-cell-therapy-landscape/?utm_source=facebook&utm_medium=social&utm_campaign=CIBMTR-2026-day-2-assoc-facebook-share-custom-graphic&utm_content=link-share06 Feb 2026 16:20 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3me7cpm7imk2nhttps://bsky.app/profile/cibmtr.bsky.social/post/3me2wxqakfs2fAttending #Tandem26 and looking for session locations in the Salt Palace Convention Center? Here are few helpful maps! @astct.bsky.social04 Feb 2026 22:39 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3me2wxqakfs2fhttps://bsky.app/profile/cibmtr.bsky.social/post/3me2ini3qks2rDr. Miguel-Angel Perales (@drmiguelperales.bsky.social) concludes the CIBMTR Concurrent Session with “Use of CIBMTR One Year Survival Calculator for Retrospective Analysis” at #Tandem26 this morning!04 Feb 2026 18:23 +0000at://did:plc:zy3fnnflddaknkoh7pfyfjee/app.bsky.feed.post/3me2ini3qks2r